Obalon therapeutics inc (OBLN)
Balance Sheet / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Dec'15
Assets
Current assets:
Cash and cash equivalents

14,100

19,400

13,513

24,684

21,187

21,552

24,212

33,478

21,108

12,083

5,827

41,712

72,975

2,324

3,356

Short-term investments

0

0

0

0

2,548

8,116

997

0

23,292

41,289

54,898

25,008

2,500

11,829

9,175

Accounts receivable, net

285

238

447

1,829

870

2,775

3,049

2,553

4,223

2,515

1,757

1,035

0

-

-

Accounts receivable, related party

-

-

-

-

-

-

-

-

-

0

0

0

515

515

636

Inventory, Net

1,936

2,048

2,107

1,860

1,580

1,955

1,842

1,867

1,418

911

747

928

827

438

363

Other Assets, Current

1,959

683

954

1,539

2,462

909

857

1,187

1,714

1,006

705

1,004

1,244

2,857

273

Total current assets

18,235

22,349

17,021

29,912

28,647

35,307

30,957

39,085

51,755

57,804

63,934

69,687

78,061

17,963

13,803

Lease right-of-use assets

1,077

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property, Plant and Equipment, Net

1,081

1,117

1,038

1,222

1,739

1,572

1,514

1,422

1,346

1,274

1,044

903

717

535

418

Lease right-of-use assets

-

1,191

1,140

1,234

-

-

-

-

-

-

-

-

-

-

-

Total assets

20,393

24,657

19,199

32,368

30,386

36,879

32,471

40,507

53,101

59,078

64,978

70,590

78,778

18,498

14,221

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

648

732

1,082

1,044

1,159

1,458

1,445

2,304

1,276

-

-

-

595

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

1,143

697

823

-

1,068

549

Accrued compensation

820

724

1,093

986

3,805

2,671

2,132

1,831

4,494

2,671

2,381

1,555

2,497

684

1,250

Deferred revenue

424

283

320

370

352

301

302

-

-

-

-

-

-

-

-

Accrued clinical expenses

-

-

-

-

-

-

-

-

-

140

192

122

-

139

913

Deferred revenue

-

-

-

-

-

-

-

337

510

193

206

171

121

-

-

Other Liabilities, Current

1,524

1,609

2,127

2,214

1,985

2,328

2,552

1,677

1,773

1,477

1,341

960

1,379

2,434

493

Operating Lease, Liability, Current

561

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of lease liabilities

-

557

468

465

-

-

-

-

-

-

-

-

-

-

-

Customer deposit from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,283

Current portion of long-term loan

0

0

5,000

19,952

9,930

523

3,965

2,961

1,958

957

-

-

0

-

747

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

882

332

Total current liabilities

3,977

3,905

10,090

25,031

17,231

7,281

10,396

9,110

10,011

6,581

4,817

3,631

4,592

5,207

5,567

Operating Lease, Liability, Noncurrent

567

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities long-term

-

687

722

819

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

0

0

0

0

48

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

46

44

0

13

26

39

-

0

-

-

Long-term loan, excluding current portion

-

-

-

-

-

9,399

5,980

6,973

7,964

8,955

9,901

9,891

9,881

9,886

9,094

Total long-term liabilities

-

687

722

819

-

9,445

6,024

6,973

7,977

8,981

9,940

-

9,881

-

-

Total liabilities

4,544

4,592

10,812

25,850

17,279

16,726

16,420

16,083

17,988

15,562

14,757

13,522

14,473

15,093

14,661

Commitments and contingencies (See Note 10)

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

Convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

70,498

54,699

Stockholders’ equity:
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2019 and December 31, 2018; 7,724,100 and 2,351,333 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively

8

8

36

24

2

23

18

18

18

17

17

17

17

1

1

Additional paid-in capital

188,271

187,574

172,162

163,538

161,859

160,130

149,285

147,905

146,474

144,757

142,307

141,424

140,898

2,015

1,002

Accumulated other comprehensive loss

-

-

-

-

-

-2

1

1

-5

-4

-19

-19

-1

5

0

Accumulated deficit

-172,400

-167,500

-163,800

-157,000

-148,754

-139,998

-133,253

-123,500

-111,374

-101,254

-92,084

-84,354

-76,609

-69,114

-56,142

Total stockholders’ equity

15,849

20,065

8,387

6,518

13,107

20,153

16,051

24,424

35,113

43,516

50,221

57,068

64,305

-67,093

-55,139

Total liabilities and stockholders’ equity

20,393

24,657

19,199

32,368

30,386

36,879

32,471

40,507

53,101

59,078

64,978

70,590

78,778

18,498

14,221